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Abstract  
Background Nanomaterials, as a new kind of materials, have been greatly applied in 
different fields due to their special properties. With the industrialization of nanostructured 
materials and increasing public exposure, the biosafety and potential influences on central nervous 
system (CNS) have received more attention. Nanosized zinc oxide (nanoZnO) was suggested to 
up-regulate neuronal excitability and to induce glutamate release in vitro. Therefore, we 
hypothesized nanoparticles of nanoZnO may lead to changes in balance of neurotransmitter or 
neuronal excitability of CNS. This study was to investigate if there were effects of nanoZnO on 
animal model of depression. Methods Male Swiss mice were given lipopolysaccharides (LPS, 
100g/kg, 100g/ml, every other day, 8 times, i.p.) from weaning to induce depressive-like 
behaviors. NanoZnO (5.6 mg/kg, 5.6mg/ml, every other day, 8 times, i.p.) was given as the 
interaction. The mouse model was characterized using the methods of open field test, tail 
suspension test and forced swim test. Furthermore, the spatial memory was evaluated using Morris 
water maze (MWM) and the synaptic plasticity was assessed by measuring the long-term 
potentiation (LTP) in the perforant pathway (PP) to dentate gyrus (DG) in vivo. Results Results 
indicated that model mice showed disrupted spatial memory and LTP after LPS injections and the 
behavioral and electrophysiological improvements after nanoZnO treatment. Conclusion Data 
suggested that nanoZnO may play some roles in CNS of mental disorders, which could provide 
some useful direction on the new drug exploring and clinical researches.  
Key words?Morris water maze; long-term potentiation; depression; hippocampus; nanoparticles 
zinc oxide (nanoZnO) 
 
 3
1  Background 
Nanotechnologies, which have developed and popularized at an increasing rate, exploit 
materials and devices with functionally organization engineered at the nanometer scale. 
Nanostructured materials, primarily defined by unique properties and determined interaction with 
other disciplines, can interact with biological systems at basic molecular levels with high 
specificity. Making use of this molecular feature, nanodevices can stimulate and interact with 
objective cells in certain ways to induce and maximize desired physiological responses [1, 2]. 
Presently, nanoscaled materials have been widely applied in many fields such as medicine, 
biotechnology, energy and environmental technology [1, 3-5]. Nanotoxicology and the potential 
effects on human body have grown in significance over recent years fueled by the surge of 
nanomaterial-based consumer products or building materials in the market. Since they can pass 
through biological membranes, nanoparticles have potential toxic effects and significant 
pathological consequences in human [3, 6-9]. Meanwhile, they’ve been recognized for their 
potential biological utility including biological science and nanomedicine [10, 11]. With the 
industrialization and increasing public exposure, nanosized materials have received more concern 
over their biosafety and underlying effects on central nervous system (CNS).   
ZnO nanoparticles are amongst the most commonly utilized nanomaterials in consumer 
products notably on account of their unique physicochemical properties [12, 13]. Some studies 
have indicated that nanoZnO affected functions of different cells or tissues [14, 15], 
biocompatibility [16] and neural tissue engineering [1, 2] , but little was known about the 
influence on CNS and CNS related diseases. NanoZnO was suggested to modulate synaptic 
transmission in vitro [4] and to change the spatial cognition capability via enhancing long term 
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potentiation (LTP) in rats [17]. It’s also suggested that exposure to nanoZnO led to a genotoxic 
potential mediated by lipid peroxidation and oxidative stress [18]. However, nanoZnO has been 
regarded as a potential utility in the treatment of cancer and/or autoimmunity due to its targeting 
potential [19]. This presented the potential application in treatment of diseases or some possible 
neuroprotection. In addition, our previous studies indicated that exposure to nanoZnO resulted in 
increases in current amplitude and excitability of acutely isolated rat hippocampal CA3 pyramidal 
neurons in vitro [4].  
Depression, as a prevalent affective disorder, affects so many individuals in the course of 
their lifetimes and has overwhelming emotional and physical symptoms [20]. A study performed 
on behalf of the World Health Organization (WHO) has reported more than half individuals with 
depression around the world are not being treated, and depression would rank the second prevalent 
cause in term of illness induced disability by 2020 [21]. However, there is little information about 
the pathogenesis of depressive disorders. Disturbances of neurotransmitters, ligands and receptors 
and decoupling of the feedback of hypothalamic-pituitary-adrenocortical (HPA) systems with 
certain impairment of the immune system are supposed to be experienced during depression with 
anhedonia and orientation alterations towards conscience and order [22]. It’s suggested that 
inflammation can induce abnormities in CNS, such as release of proinflammatory cytokines, 
excitatory amino acids and nitroxidative species which may be responsible for cognition deficits 
and other pathological diseases [23]. Activation of the peripheral innate immune system through 
the administration of lipopolysaccharide (LPS) induces depressive-like behavior that can be 
attenuated by chronic antidepressant administration. Both clinical reports and research data 
revealed that activation of the tryptophan catabolizing enzyme indoleamine 2, 3-dioxygenase 
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(IDO) was greatly involved. Through regulating the ratio of plasma kynurenine to tryptophan, the 
IDO further alters serotoninergic and glutamatergic neurotransmission. Alternatively,?kynurenine, 
as the major product of peripheral tryptophan degradation, can be transported into the brain 
through blood-brain barrier (BBB) and metabolized to produce neuroactive glutamatergic 
compounds, further resulting in the disorder of transmission system [23]. Accompanied by 
cognitive dysfunction, more studies are needed aiming at insights into the neuropathology of 
depression and offering promising alternatives or potential therapeutic action [24]. In this study, 
LPS repeated administrations strongly resemble the core features tested by behavioral assays, 
suggesting further examinations of the behavioral and neurophysiologic changes may shed light 
on neurobiology and treatments of depression.   
According to the knowledge above, nanoZnO may play some potential role in CNS and 
perhaps during development processes of diseases through mediating neuronal excitability or even 
release of neurotransmitters. The present study was determined to see if there were effects of 
nanoZnO on cognitive deficits and long-term potentiation (LTP) changes in mice with 
depressive-like behaviors.  
2  Methods 
2.1 Reagents  
Lipopolysaccharide (LPS, L-3129, serotype 0127:B8) was purchased from Sigma (St. Louis, 
MO). Before the injection, the fresh solution was prepared by diluting stock solution to final dose 
with sterile endotoxin-free isotonic saline and was administered intraperitoneally (i.p.). The stock 
solution was stored in 4°C. 
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The particles of nanoZnO in our research were provided by IntriciQ Materials, Farnborough, 
Hants GU14 0LX, UK, occurring as white powder which is nearly insoluble in water but in acids 
and bases. It was showed by the transmission electron microscopy (TEM, Tecnai G2 20 S-TWIN, 
FEI, USA) images that nanoZnO particles were with the sizes of 20-80 nm [4]. The stock solution 
of nanoZnO was prepared with sterile isotonic saline. The final concentration suspension was 
diluted and dispersed by ultrasonic vibration for 20 min before every use. 
2.2 Animals 
All animal care and use were conducted in accordance with approved institutional animal 
care procedures. Male Swiss mice aged 21 days old (weaning) were purchased from the 
Laboratory Animal Center, Academy of Military Medical Science of People’s Liberation Army, 
and were reared in standard colony rooms in animal house of Medical School, Nankai University. 
Animals had free access to food and water in a controlled room with constant temperature 
(24±2°C) and humidity (50-60 %) with a normal light/dark cycle during all phases of experiments. 
All surgical procedures and behavioral tests took place during the light phase. Twenty-nine mice 
were randomly divided into four groups, which were control group (n=7, sterile saline, 30 g/kg, 
0.9g/100ml, every other day), LPS group (n=8, LPS, 100g/kg, 100g/ml, every other day), LPS+ 
nanoZnO group (n=8, LPS, 100g/kg, 100g/ml, every other day, nanoZnO, 5.6 mg/kg, 5.6mg/ml, 
every other day) and nanoZnO group (n=8, nanoZnO, 5.6 mg/kg, 5.6mg/ml, every other day). 
Mice were intraperitoneally injected (i.p.) respectively from weaning every other day. Injections 
were totally 8 times in each group. In the present study, we employed i.p. as the delivery pathway 
to avoid surgical damages. In addition, it’s been clarified that nanoparticles through i.p. showed a 
biodistribution in the brain [17, 25-28]. 
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All experiments were carried out following the guidelines of the Beijing Laboratory Animal 
Center, and approved by the Ethical Commission at Nankai University.  
2.3 Behavioral experiments 
All behavioral experiments were performed on the day after injections. And all tests were 
performed in the dark room of the light cycle.  
Forced swim test - the forced swim test (FST) was conducted basically and essentially as 
described previously [21, 29]. The forced swim apparatus consisted of a cylinder container (23 cm 
in diameter and 31 cm in height) filled with water (maintained at 23±1 °C) to a depth of 15 cm. 
For each trial, mice were placed into the water gently and individually for 6 min and then were 
returned to their home cage. The water was changed between tests. During the test, the duration of 
immobility defined as an absence of movement necessary to keep the head above the water or 
climb upward-directed against the walls was determined over the last five minutes. Longer 
duration of immobility indicated the stronger depressive-like behavior. 
Tail suspension test - we constructed the procedure of tail suspension test (TST) as described 
by Steru et al essentially [21, 30, 31]. Mice were taken from their home cage and a small piece of 
paper adhesive tape was attached approximately 2 cm from tip of the tail. A single hole was 
punched in the tape and mice were hung individually for a period of 10 min on a fixed hook. Keep 
the mice’s heads about 20 cm above the floor. Animals would wriggle to avoid this aversive 
situation resulting from the suspension and body position. The time of immobility was determined 
at activity levels that excluded all movements and only encompass immobility. More time of 
immobility indicated the stronger depressive-like behavior.  
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Open field test - the open field test (OFT) was referenced from procedures of Grønli et al to 
assess the effects on locomotor activity. The apparatus consisted of a square arena (40 cm long × 
45 cm wide × 45 cm high) with a certain inner area. The floor was divided into 16 equal squares 
by black-colored grids. In brief, each mouse was placed in one corner of the outer area and 
allowed to explore for 5 min. Locomotor activity was recorded and measured by the number of 
line crossings and rearings over a five-min period. Counting was done by a well-trained observer 
who was blind to the treatments. The floor was wiped thoroughly after each trial. Fewer times of 
crossing and rearings indicated the stronger anxiety behavior. 
2.4 Spatial working memory 
All these procedures were performed right following all behavioral tests. 
Mice were trained to learn the position of the invisible hidden escape platform using a 
standardized Morris water maze (MWM) procedure to monitor and evaluate their hippocampus 
dependent spatial learning and memory.  
The equipment of MWM consisted of a tank that was 120 cm in diameter and 60 cm in height, 
which was filled with water to the depth of 45 cm deep and maintained at 23±1°C by an automatic 
heater. Black nontoxic ink was added to make the water opaque. The tank was divided into four 
equal quadrants (I, II, III, and IV) by two imaginary perpendicular lines crossing in the center of 
the tank. A movable black circular platform (5 cm in diameter) was located in the center of 
quadrant III which is supposed to be the target quadrant. The platform submerged 1-2 cm below 
the water surface so that mouse could easily climb onto to escape from water. A camera located 
above the center of the maze and a computerized animal tracking system (Ethovision 2.0, Noldus, 
Wagenigen, Netherlands) were used to monitor and relay images. Data from the trials were 
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collected for off-line analyzing. The environment was kept lightless and noiseless, maintaining 
visual extra-maze clue and furnishment immobile and minimizing the noise disturbance.  
The MWM consisted of two sections: place navigation and spatial probe. The animals were 
subjected to training trials for five consecutive days. Mice were randomly placed into water facing 
the pool wall individually from the preset starting points. The starting location varied among four 
equidistant points around the perimeter of the apparatus. Subsequent starting points proceeded in a 
clockwise manner for the ensuing trials. Briefly, the location of the platform remained constant 
and mice were allowed to swim for 60 s or until they located the platform. Mice that failed to 
locate the platform within 60 s were guided manually to the platform and remained for at least 5 s 
before returning to their home cage. There was a 5min interval among trials. 
During the spatial probe, the platform was removed from the tank. Mice were released into 
water and allowed to swim for 60 s individually from the starting point which was in the opposite 
of the target quadrant. The time that each subject spent in which the platform had been located 
during the training was recorded.  
Performance parameters in MWM determined included latency to the platform, quadrant 
dwell time, times of crossing and swimming speed. 
2.5 Electrophysiological recordings 
After completion of all behavioral assays, the electrophysiological recording was measured in 
vivo. Synaptic responses were quantified as the field excitatory postsynaptic potential (fEPSP) 
extracellularly recorded in the perforant pathway (PP) to dentate gyrus (DG) region. After 
anesthetized by 5% urethane (0.3ml/10g, i.p.), the mouse was placed in a stereotaxic frame 
(Narishige, Japan). At the electrode inputting region of the left side, the scalp was incised and a 
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small hole was drilled in the skull using a dental drill. A concentric bipolar stimulating electrode 
was slowly implanted into the PP (2.0 mm posterior to the bregma, 1.5 mm lateral to midline, 
1.5-2.0 mm ventral below the dura). A monopolar extracellular stainless steel recording electrode 
was positioned into DG region (0.5 mm anterior to the bregma, 3.2 mm lateral to midline, 1.5-2.0 
mm ventral below the dura). During recording, the optimal depths of electrodes were determined 
using the electrophysiological criteria.  
A stable normalized baseline was recorded for 15 min after positioning the electrodes. Then a 
high frequency stimulus (HFS, 10 pulses at 100 Hz for 2 s repeated 10 times) was delivered at test 
intensity for induction of LTP in the DG. The fEPSPs were recorded at 20 kHz sampling rate 
(Scope software, PowerLab, AD Instruments, Australia) every 30 s for 60 min. The fEPSPs were 
amplified (×100), filtered at 5-5 kHz, digitized and recorded using Scope software (Power Lab, 
AD Instruments, Australia). The initial analysis of data was done in Clampfit 9.0 (Molecular 
Devices, Sunnyvale, CA, USA). The fEPSPs slope was measured as the average slope from 20 % 
to 80 % of the decreasing phase to measure the synaptic efficacy. 
2.6 Statistical analysis 
All data were presented as mean ± SEM and analyzed using SPSS 16.0 and Origin 8.0. 
Escape latencies and swimming speeds were compared using repeated measures ANOVA. Data 
from spatial probe and LTP recording were normalized and compared using a one-way ANOVA, 
followed by a post hoc pairwise multiple comparison procedure using the Fisher’s LSD method if 
the interaction was significant. The behavioral results were analyzed with a two-way ANOVA. 
The probability level interpreted as statistically significant was P<0.05. 
3  Results 
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3.1 Changes in behavioral tests 
To check depressive-like behaviors, the behavioral assays, including open field test, forced 
swim test and tail suspension test which have been used widely to evaluate this animal model in 
related researches were conducted. 
Numbers of rearing and crossing in OFT were counted and compared between groups. The 
data were thought to reflect the abilities of exploration and spontaneous locomotion. Mice usually 
struggle to escape from these situations, interspersed with periods of immobility that has been 
interpreted as “behavioral despair” [20, 32]. So the time of immobility in FST and in TST was 
calculated to glint changes linked to the depression directly and clinically. 
Comparisons revealed that mice of LPS group took more time to keep immobile in FST than 
that of control (122.88±6.10, 83.38±2.82, P<0.001) and LPS+nanoZnO group (122.88±6.10, 
84.16±3.52, P<0.001) (as showed in Fig. 1.A ). Mice of nanoZnO group took slightly less time to 
keep immobile than that of control group (69.88±3.36, 83.38±2.82, P>0.05) at the same time, but 
there was no difference between LPS+nanoZnO group and control one (P>0.05). In TST, there 
were similar results that mice of LPS group exhibited increased immobility more than that of 
control and LPS+nanoZnO groups with significant differences (197.25±9.50, 108.38±3.04, 
P<0.001; 197.25±9.50, 159.16±5.13, P<0.001) (as showed in Fig. 1.B). In nanoZnO group, mice 
showed less time than that of control group (94.38±3.00, 108.38±3.04, P<0.01).  
In OFT, there were significant differences between LPS group and control group in rearings 
(22.00±0.97, 40.88±1.58, P<0.001) but not in crossings (49.16±2.56, 55.00±1.88, P>0.05) 
respectively (as showed in Fig. 1.C and D). In LPS+nanoZnO group, there was significant 
increase in numbers of crossings than that of LPS group but not the control group (57.14±2.31, 
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49.125±2.56, P<0.05; 57.14±2.31, 55±1.88, P>0.05). Meanwhile, for the number of rearings, it 
displayed some different results. LPS group showed markedly reduced number of rearings than 
that of control group (22±0.98, 40.875±1.58, P<0.001) but there was no significant difference 
between LPS group and LPS+nanoZnO group (22±0.98, 25,667±1.667, P>0.05). Also, mice of 
nanoZnO group displayed significantly increased number of rearings than that of control group 
(49.25±2.28, 40.875±1.58, P<0.01). While rearing numbers were significantly attenuated in 
LPS+nanoZnO group than those of control group. Collectively, these data strongly suggested that 
activation of the peripheral innate immune system with LPS administrations induced a 
depressive-like syndrome in mice and meanwhile the treatment of nanoZnO resulted in some 
improvements in behavioral response and emotional normalization to inescapable stress which 
might be sighted.   
3.2 Changes of spatial cognition in MWM 
To determine whether the administration of LPS efficiently induced depressive-like behaviors 
in mice with learning and memory deficits and if the treatment of nanoZnO particles could reverse 
or improve these impairments, the suspension of nanoZnO was injected in mice intraperitoneally, 
and changes were analyzed during the test of MWM. 
 In place navigation, mice of all groups took decreasing time over the course of the training 
to locate the submerged platform indicating that mice could definitely get and remember the 
location of the hidden platform through training and exhibit increasingly efficient exploratory 
strategies during the following trials (as showed in Fig. 2.A). Overall repeated ANOVA analyses 
showed there were significant differences from day 1 to day 4 between LPS groups and control 
group (P<0.01 on day 1 and P<0.05 on day 2, 3 and 4). And on day 4 and 5, there were also 
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significant differences between LPS group and LPS+nanoZnO group (P<0.05). Data also showed 
that there were no statistical differences since day 2 until the end of the test (P<0.05 on day 1).   
In spatial probe trial, performances were assessed by the percentage of time spent in the maze 
quadrant (quadrant dwell time) and mean platform crossings (as showed in Fig. 2.B and Fig. 2.C). 
The ANOVA analyses showed that mice of LPS group failed to locate the platform in the target 
quadrant. Percentages of time in the target quadrant and numbers of platform crossings were less 
in LPS group than those of control group (28.121±2.24, 48.9±3.002, P<0.001; 2±0.408, 
4.285±0.333, P<0.01), however there were prominent improvements in LPS+nanoZnO group 
especially quadrant dwell time (44.221±3.24, 28.121±2.24, P<0.01) but not in numbers of 
platform crossings (2.875±0.307, 2±0.408, P>0.05). Meanwhile, there was no significant 
difference in the target quadrant and numbers of platform crossings between nanoZnO group and 
control group (55.557±3.939, 48.9±3.002, P>0.05; 4.857±0.333, 4.285±0.333, P>0.05).  
In addition, the swimming speeds of each group remained constant throughout the test with 
no significant differences between groups (P>0.05; as showed in Fig. 2.D). And the motor ability 
of animals was not changed and did not result the difference between groups. The results 
suggested that the treatment of nanoZnO partially reversed the learning and memory impairment. 
3.3 Changes of LTP recording within the PP-DG pathway 
Stimulation of PP evoked a basal fEPSPs in DG area and HFS induced potentiation of 
synaptic transmission for at least one hour in LTP recording in vivo.  
To further study the mechanisms of nanoZnO particles, slopes of fEPSPs were normalized 
and recorded for 15 min as baseline as delineated, and after HFS, slopes of fEPSPs increased 
immediately and stabilized above the baseline level. The ANOVA analysis revealed that after HFS, 
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LTP was not efficiently induced in mice of LPS group consistent with the depressed slopes (as 
showed in Fig. 3.A). Slopes of LTP during the time course of the last 30mins were also calculated 
and compared for each (as showed in Fig. 3.B). It was found that the fEPSPs slopes were 
significantly decreased in LPS group compared with control group (110.16±5.63, 157.09±6.70, 
P<0.001) and LPS+nanoZnO group (110.16±5.63, 139.78±8.02, P<0.001), but there was a 
significant enhancement between nanoZnO group and control group (206.225±6.06, 157.09±6.70, 
P<0.001).  
4 Discussion 
It’s reported that nanoengineered materials might be used as approaches to interact with 
neurons to stimulate adhesion and growth and be chemically functionalized by attaching large 
varieties of biological molecules to cellular outer surface (for example, antibodies, peptides and 
trophic factors). Different nanosized particles or materials have been applied as nanoenabled 
drug-delivery system. By passing the BBB and translocating to the blood stream, complex can 
facilitate certain drugs efficiency and the release of biochemical, providing novel approaches for 
transporting therapeutics and targeted therapy in the treatment of brain cancer, neurodegenerative 
diseases, and used as a sought-after utility in nanomedicine and neuroscience [1, 2, 33-36]. In a 
different approach, nonporous silicon coated in electrodes was observed in PC12 cells to derive 
precursor cells, increase neurite outgrowth and decrease glial responses. Substantia nigra neurons 
cultured on silicon dioxide (SiO2) surfaces containing different nanoscale topographies had 
differential cell adhesion properties [1]. It’s concluded that nanomaterials could influence central 
nervous system in vitro in a positive way which indicated that nanosized mental materials might 
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act to be neuroprotective or promotive and the applications were probably correlated with physical 
sizes. 
It’s been understood that nanostructured zinc oxide have been widely applied in many aspects 
due to special properties and certain levels of biocompatibility. Some typical distinctive properties 
of nanoZnO were the capability of antibacterial [37, 38], generation of reactive oxygen species 
(ROS) [39, 40] and membrane damage possibly caused by generation of ROS [37, 38, 40]. They 
are consistent with the toxic effects that have recently received lots of concern. But little was 
known about its potential beneficial role either in correlational studies or in diseases. Previous 
research in our lab supported that nanoZnO had effects on acutely isolated rat hippocampal CA3 
pyramidal neurons. By enhancing the current amplitude of INa and IK and shifting neuronal 
excitability, probably mediating neurotransmitter release, nanoZnO may regulate ionic 
homeostasis and the physiological functions of neurons and have potential influence in CNS 
which shed light on the possible application and treatment in neurotransmitter system disorders in 
CNS [4]. Meanwhile, understanding the pathophysiological mechanisms by which inflammation 
and depression are linked has wide ranging implications that spans both disciplines and clinical 
specialties. As IDO activation was proposed to mediate a change in serotoninergic 
neurotransmission during the development of depression, the hypothesis was raised that nanoZnO 
may provide some positive benefit to the cognitive impairment or other injuries accompanied by 
the depressive-like behaviors. In this study data showed that nanoZnO improved the behavioral 
and cognitive deficits in a mice model of depression, examining by behavioral assays and 
electrophysiology respectively. 
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Open field test, tail suspension test and forced swim test are usually adopted to detect and 
evaluate depressive-like behaviors [21, 41]. Results obtained in this study showed that mice of 
LPS group performed with increased durations of immobility in TST and FST and less numbers of 
crossings and rearings in OFT. This was associated with the decreased exploratory behaviors and 
locomotor abilities during depression when animals happened to be susceptible to hopeless and 
despair. In concert with previous reports, abilities to explore the surrounding environment and the 
spontaneous ability were severely impaired in LPS group representing the behavioral and 
emotional changes which could imitate and agree with clinical symptoms of depression. 
Additionally, mice of LPS+nanoZnO group appeared positive changes signing benefits resulted 
from administrations of nanoZnO. 
Morris water maze (MWM) is a well-validated method for evaluating learning and memory. 
It can reliably express hippocampus-related acquisition and the persistence of spatial memory [42, 
43]. Results in this study revealed that with the increase of training days, escape latencies were 
consistently decreased and there was prominent improvement during the last two days between 
mice of LPS+nanoZnO group and LPS group. Meanwhile there was significant difference 
between LPS group and control, indicating the disruption of learning and memory during 
depression. This is in accordance with former reports suggesting that acquisition and retention 
capacities were impaired in depression model. Mice in control group learned quickly and 
maintained the time of locating the submerged platform after the first day of training. The learning 
ability was mainly reflected by the performances in place navigation section. Our data displayed 
that escape latency was reduced with the increase of training between groups, whereas the 
swimming speed remained constant suggested that motor ability was not involved in prolonged 
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latencies. Results also suggested that treatment of nanoZnO attenuated the impairment of learning 
acquisition effectively in LPS group and LPS+nanoZnO group. Furthermore, the persistence of 
spatial memory was mainly reflected through mouse performances in spatial probe stage. It’s 
observed that numbers of platform crossing and quadrant dwell time were markedly decreased in 
LPS group. However, the treatment with nanoZnO ameliorated these defects efficiently. Some 
previous reports suggested that chronic neuroinflammation induced direct functional impairments 
of synaptic plasticity underlying learning and memory process [24, 44], and over-expressions of 
cytokines causing direct neuron injuries [45, 46], which were consistent with the performance in 
MWM in our study. In brief, our results indicated that inflammation was sufficient to induce 
learning and memory dysfunction and resemble certain deficits and clinical symptoms, and 
administrations of nanoZnO could improve the memory ability in mice with depressive-like 
behaviors.  
Hippocampus, conducting a major function of cognition and memory, depends on synaptic 
transmission properties mainly referring to the neuron network and synaptic functions [44]. By 
different means of identifying and characterizing, LTP usually acts as one functional index of 
synaptic plasticity and is one major form of experience-dependent alteration of excitatory synaptic 
transmission. It’s definitely supposed to be the cellular mechanism underlying memory formation 
to manifest the strength of synaptic junctions connecting neurons and changing with experience 
[47, 48]. Growing evidence indicates increase in the size of fEPSPs can be observed after 
induction by HFS, which is consistent with enhancement of synaptic plasticity and cognition [49]. 
Along with function of dentate gyrus (DG) in hippocampus to be understood and its important role 
in memory and formation of LTP focused [50-52], we recorded the LTP in PP-DG area in vivo as a 
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major neurophysiologic index. Results showed that the normalized slope of the fEPSPs was 
seriously abolished in LPS group. And data obtained from our study were in agreement with the 
above result in MWM. Furthermore, it exhibited apparent reinforcement in slopes of fEPSPs in 
mice of LPS+nanoZnO group, while in nanoZnO group LTP showed significant enhancement. 
According to previous studies, LTP deficits in LPS group could be connected with many reasons, 
such as cytokines [53, 54], reactive nitroxidative species (RNS) [23], or ion channel 
dysfunction[55]. It was suggested that cytokines or ROS/RNS could induce direct neuron injures, 
decrease the volume of hippocampus [56] or disturb transmitter system. Results also matched with 
previous outcome that nanoZnO enhanced neuron excitability [4, 57] and mediated 
neurotransmitter release, and even regulated synaptic plasticity. Research in emerging area of 
nanotechnology demonstrated that the feasibility of functionalizing glass attached with inhibitory 
transmitter GABA (-amino butyric acid) through particular molecular interactions in vitro. 
Applications of nanotechnologies for neuroprotection have focused on limiting the damaging 
effects of free radicals generated after injury, which played an important role in neuropathological 
process contributing to CNS ischemia and degenerative disorders. Data (not shown) from HELC 
also indicated that nanoZnO treatment significantly enhanced the release of hippocampal 
transmitter by increasing the concentration of -GABA in LPS+nanoZnO group [58]. Additionally, 
increased prevalence of comorbid depressive symptoms appears during kinds of conditions (such 
as aging, obesity) and diseases (such as atherosclerosis, rheumatoid arthritis), all of which have 
common chronic neuroinflammation [21, 59, 60], undergoing over-expressions of inflammatory 
cytokine during the peripheral system. Cytokines modulate release of transmitters, Ca2+ signal 
pathway and synaptic function which played an important role in physiological response and 
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memory processing besides inflammation and nervous homeostasis [61]. Recent reports from our 
lab revealed that through shifting LTP to a higher level than that in the LPS group, spatial memory 
and cognition might be improved to some degree. What’s more, the over-enhanced LTP in 
nanoZnO group damaged spatial cognition and capability. This bidirectional effect of nanoZnO 
might be explained by disrupting the balance of stability and flexibility of synaptic plasticity [17]. 
Certainly, the effect of nanoZnO on fEPSPs may possibly through a mechanism that is unrelated 
to the up-regulation of Na and K channels and still need further investigation to interpret. Briefly, 
our results suggested nanoZnO may benefit mice behaviorally and acts to be neuroprotective in 
some ways. In the light of other research, zinc was presumed to act as antidepressive and shed 
light on some other possible mechanisms involved in effects of nanoZnO [62, 63].  
Interestingly, our data are not strictly consistent prior reports. Some mentioned that nanoZnO 
may cause adverse effects partly due to the generation of reactive oxygen species (ROS) [37, 40, 
64], release of zinc ions [38, 65, 66], membrane damage through direct nanoparticle-cell 
membrane wall interaction or generation of ROS [37, 38, 40]. With regard to nervous tissue, data 
showed that Neuro-2A cells and human neural cells and fibroblasts underwent apoptosis and 
necrosis when exposed to nanoZnO [67, 68]. A recent study led by Nanyang Technological 
University (NTU) has found that nanoZnO could potentially cause cancer by damaging the DNA 
which in turn activates p53, which acts as one of the most important tumor suppressors and 
protects cells from developing cancer phenotypes [69].  
Collectively, the dosage and particle physical diameter used in this study were proposed to be 
responsible for this protection and need to be investigated further. Some studies considered 
nanosized particles act in different ways related with particle physical sizes.  
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5 Conclusion 
In summary, this study verified that zinc oxide nanoparticles could ameliorate the behavioral 
and cognitive impairment in mice with depressive-like behaviors, probably through up-regulating 
neuronal synaptic plasticity and functions in the area from perforant pathway to the dentate gyrus. 
More investigations will be required for a better understanding of the neuro-effect of nanosized 
materials and the underlying mechanisms, which provide potential therapeutic targets and clinical 
relevance on depression. And even more possible function mechanisms might be revealed in the 
further research. 
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Figure legends  
 
Fig. 1. Performances in behavioral assays. Behavioral tests including forced swim test (FST), 
tail suspension test (TST) and open field test (OFT). Time of immobility was evaluated in the FST 
and TST as showed in A and B separately. Numbers of crossings and rearings were counted in the 
OFT as showed in C and D. Each data represents mean±SEM. *P<0.05, ** P<0.01, ***P<0.001. 
 
Fig. 2. Performances of mice in MWM. Escape latency (A) from the place navigation session, 
percent of platform quadrant dwell time (B) and numbers of platform crossings (C) in spatial 
probe stages and the swimming speed calculated for each training session (D) were presented as 
mean±SEM. There are significant differences when P<0.05. In Fig.2 (A), *P<0.05, comparison 
between LPS+nanoZnO vs. Control; ## P<0.01, comparison between LPS vs. Control; ?P<0.05, 
??P<0.01, comparison between nanoZnO vs. Control; * P<0.05, comparison between LPS vs. 
LPS+nanoZnO. 
 
Fig. 3. Representative fEPSPs evoked by HFS in PP-DG area in vivo. fEPSPs were 
continuously recorded and normalized prior to HFS as baseline and 1 h after HFS as the LTP (A). 
Values are expressed as percentage of change relative to baseline. Magnitude of LTP, determined 
as responses between 30 and 60 min after HFS (B) were represented as the mean±SEM. There are 
significant differences in different groups (P< 0.05). 
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